从2017年国家出台的医改文件来看,主要是延续2016年的工作思路,继续推进更加系统化的改革。药品制度改革、医联体建设、公立医院改革、医保支付制度改革是2017年的四个重点,而这四项改革又是彼此密切相关的。在下一步的医改中能否取得实质性进展,很大程度上取决于“三医联动”中的“医保”能否起到规范医疗机构行为和控制药品价格的基础性作用。而2018年3月的新一轮机构改革恰是在这一方向上的努力——新组建的“国家医疗保障局”将大大提高医保的作用,新的“国家卫生健康委员会”承担协调推进“大健康”战略的角色,以及取消医改办,医改由“运动式”改为“常态化”。
<<2017 mainly continued the work ideas of 2016 and continued to advance the more systematic reform,as seen from the 2017 documents.The four keys of 2017 were drug system reform,healthcare consortium construction,public hospital reform,medical insurance payment system reform,which are closely linked with each other.Whether substantial progress can be achieved largely depends on whether the “medical insurance” in the coordinated medical service,medical insurance,and pharmaceutical reforms can play the fundamental role of regulating medical institution behaviors and controlling drug prices in the following medical reform.And the new round of institutional reform in March 2018 shows the effort in this direction:the new founding of the“State Medical Insurance Administration”,and it will largely increase the role of medical insurance.The new National Health Commision plays a strategic role of coordinating and pushing the “big health” strategy.And the cancellation of the Medical Reform Office,changes the medical reform from a campaign to a normal.
<<Keywords: | Public HospitalNew Medical Reform“Two-Invoice System”Medical AssociationMedical and Health Resources |